Karl R Abi-Aad1, Rami James N Aoun2, Rudy J Rahme3, Jennifer D Ward3, Jason Kniss3, Mary Jeanne Kwasny4, Mithun G Sattur1, Matthew E Welz1, Bernard R Bendok5. 1. Department of Neurological Surgery, Mayo Clinic, 5777 E Mayo Boulevard, Phoenix, AZ, 85054, USA. 2. Department of General Surgery, Cleveland Clinic, Cleveland, OH, USA. 3. Department of Neurological Surgery, Northwestern University, Chicago, IL, USA. 4. Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. 5. Department of Neurological Surgery, Mayo Clinic, 5777 E Mayo Boulevard, Phoenix, AZ, 85054, USA. bendok.bernard@mayo.edu.
Abstract
PURPOSE: Aneurysm recanalization constitutes a limitation in the endovascular treatment of intracranial aneurysms using conventional bare platinum coils. The development of platinum coils coupled with hydrogel polymers aimed at decreasing the rates of recurrence by way of enhanced coil packing density and biological healing within the aneurysm. While enhanced occlusion and durability has been shown for the first generation hydrogel coils, their use was limited by technical challenges. Less data is available regarding the second-generation hydrogel coils which have been designed to perform like bare platinum coils. METHODS: The new generation Hydrogel Endovascular Aneurysm Treatment Trial (HEAT) is a multicenter, randomized controlled trial that compares the health outcomes of the second-generation HydroCoil Embolic System with bare platinum coils in the endovascular intracranial aneurysms. The primary endpoint is aneurysm recurrence, defined as any progression on the Raymond aneurysm scale, over a 24-month follow-up period. Secondary endpoints include packing density, functional independence, procedural adverse events, mortality rate, initial complete occlusion, aneurysm retreatment, hemorrhage from treated aneurysm, and any aneurysm recurrence. RESULTS:Patient recruitment initiated in June 2011 and ended in January 2016 in 46 centers. Six hundred eligible patients diagnosed with an intracranial aneurysm, ruptured or unruptured were randomly assigned to one of the two treatment arms. CONCLUSION: The HEAT trial compares the durability, imaging, and clinical outcomes of the second-generation hydrogel versus bare platinum coils in the endovascular treatment of ruptured or unruptured intracranial aneurysms. The results of this trial may further inform current endovascular treatment guidelines based on observed long-term outcomes.
RCT Entities:
PURPOSE:Aneurysm recanalization constitutes a limitation in the endovascular treatment of intracranial aneurysms using conventional bare platinum coils. The development of platinum coils coupled with hydrogel polymers aimed at decreasing the rates of recurrence by way of enhanced coil packing density and biological healing within the aneurysm. While enhanced occlusion and durability has been shown for the first generation hydrogel coils, their use was limited by technical challenges. Less data is available regarding the second-generation hydrogel coils which have been designed to perform like bare platinum coils. METHODS: The new generation Hydrogel Endovascular Aneurysm Treatment Trial (HEAT) is a multicenter, randomized controlled trial that compares the health outcomes of the second-generation HydroCoil Embolic System with bare platinum coils in the endovascular intracranial aneurysms. The primary endpoint is aneurysm recurrence, defined as any progression on the Raymond aneurysm scale, over a 24-month follow-up period. Secondary endpoints include packing density, functional independence, procedural adverse events, mortality rate, initial complete occlusion, aneurysm retreatment, hemorrhage from treated aneurysm, and any aneurysm recurrence. RESULTS:Patient recruitment initiated in June 2011 and ended in January 2016 in 46 centers. Six hundred eligible patients diagnosed with an intracranial aneurysm, ruptured or unruptured were randomly assigned to one of the two treatment arms. CONCLUSION: The HEAT trial compares the durability, imaging, and clinical outcomes of the second-generation hydrogel versus bare platinum coils in the endovascular treatment of ruptured or unruptured intracranial aneurysms. The results of this trial may further inform current endovascular treatment guidelines based on observed long-term outcomes.
Authors: M H T Reinges; T Krings; A Y Drexler; A Ludolph; B Sellhaus; M Bovi; S Geibprasert; R Agid; K Scherer; F J Hans Journal: Interv Neuroradiol Date: 2010-07-19 Impact factor: 1.610
Authors: Shah-Naz Hayat Khan; Christopher Nichols; John J Depowell; Todd A Abruzzo; Andrew J Ringer Journal: Clin Neurol Neurosurg Date: 2011-08-20 Impact factor: 1.876
Authors: Ron C Gaba; Sameer A Ansari; Soma Sinha Roy; Franklin A Marden; Marlos A G Viana; Tim W Malisch Journal: Stroke Date: 2006-05-04 Impact factor: 7.914
Authors: Nohra Chalouhi; Cory D Bovenzi; Vismay Thakkar; Jeremy Dressler; Pascal Jabbour; Robert M Starke; Sonia Teufack; L Fernando Gonzalez; Richard Dalyai; Aaron S Dumont; Robert Rosenwasser; Stavropoula Tjoumakaris Journal: J Neurosurg Date: 2014-09-05 Impact factor: 5.115
Authors: P M Meyers; H C Schumacher; R T Higashida; C P Derdeyn; G M Nesbit; D Sacks; L R Wechsler; J B Bederson; S D Lavine; P Rasmussen Journal: AJNR Am J Neuroradiol Date: 2010-01 Impact factor: 4.966
Authors: Bernard R Bendok; Karl R Abi-Aad; Jennifer D Ward; Jason F Kniss; Mary J Kwasny; Rudy J Rahme; Salah G Aoun; Tarek Y El Ahmadieh; Najib E El Tecle; Samer G Zammar; Rami James N Aoun; Devi P Patra; Sameer A Ansari; Jean Raymond; Henry H Woo; David Fiorella; Guilherme Dabus; Genevieve Milot; Josser E Delgado Almandoz; John A Scott; Andrew J DeNardo; Shervin R Dashti Journal: Neurosurgery Date: 2020-05-01 Impact factor: 4.654
Authors: Jacquelyn MacDonell; Nicholas C Field; Pouya Entezami; Junichi Yamamoto; Alan S Boulos; John C Dalfino; Alexandra R Paul Journal: Brain Circ Date: 2022-03-21